Can-Fite BioPharma   Report issue

For profit Phase 2 Phase 3
Founded: Petah-Tikva Israel (1994)

Organization Overview

First Clinical Trial
2006
NCT00280917
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Can-Fite BioPharma | Can-Fite BioPharma Ltd